• Latest
  • Trending
  • All
  • News
Almost every American qualifies for paxlovid

Almost every American qualifies for paxlovid

May 19, 2022
A Wild Time Capsule in North Dakota Is This Week’s Most Popular Home

A Wild Time Capsule in North Dakota Is This Week’s Most Popular Home

June 25, 2022
5 Lovely Lake Homes Priced Below a Million Bucks

5 Lovely Lake Homes Priced Below a Million Bucks

June 25, 2022
Clarence Thomas: Court Should Reconsider Gay Marriage, Birth Control Decisions Next After Overturning Roe

Clarence Thomas: Court Should Reconsider Gay Marriage, Birth Control Decisions Next After Overturning Roe

June 25, 2022
Clarence Thomas: Court Should Reconsider Gay Marriage, Birth Control Decisions Next After Overturning Roe

Clarence Thomas: Court Should Reconsider Gay Marriage, Birth Control Decisions Next After Overturning Roe

June 25, 2022
Germany’s top energy regulator said the country can last just 2.5 months without Russian gas, and  there will be a ‘difficult’ autumn and winter ahead

Germany’s top energy regulator said the country can last just 2.5 months without Russian gas, and there will be a ‘difficult’ autumn and winter ahead

June 25, 2022
Consumers have never hated the U.S. economy this much—it’s a huge recession warning sign

Consumers have never hated the U.S. economy this much—it’s a huge recession warning sign

June 25, 2022
It seems NFT-themed Bored & Hungry restaurant no longer accepts crypto

It seems NFT-themed Bored & Hungry restaurant no longer accepts crypto

June 24, 2022
Celsius Network hires advisers ahead of potential bankruptcy: Report

Celsius Network hires advisers ahead of potential bankruptcy: Report

June 24, 2022
Could Crypto Regulation Actually Shift from the SEC to CFTC?

Could Crypto Regulation Actually Shift from the SEC to CFTC?

June 24, 2022
PancakeSwap: Your Recipe to a Sweet Life of CAKE Farming 

PancakeSwap: Your Recipe to a Sweet Life of CAKE Farming 

June 24, 2022
EUR/GBP: Renewed Brexit fears may start to weigh on sterling – Danske Bank

EUR/GBP: Renewed Brexit fears may start to weigh on sterling – Danske Bank

June 24, 2022
EUR/USD could still dip back to the recent low of 1.0350 – Rabobank

EUR/USD could still dip back to the recent low of 1.0350 – Rabobank

June 24, 2022
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Saturday, June 25, 2022
  • Login
WallStreetReview
  • Home
  • News
No Result
View All Result
WallStreetReview
No Result
View All Result
Home News

Almost every American qualifies for paxlovid

by Editor
May 19, 2022
in News
0
Almost every American qualifies for paxlovid
491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

The US is in the middle of a quiet, but severe covid wave.

A third of Americans live in areas with such a high concentration of covid that the Centers for Disease Control and Prevention is once again recommending masking up.

Hospital admissions with covid are now up to about 3,000 a day, but people who are vaccinated and boosted are expected to only experience mild cases that can be treated at home. Doctors can prescribe the antiviral paxlovid to qualifying patients in the US, though many are struggling to get prescriptions for the drug. The treatment is free.

The Food and Drug Administration has given emergency use authorization of paxlovid to people with specific conditions, so many might not think they are entitled to the treatment. But this isn’t the case: the qualifying parameters are broad enough that most Americans who test positive for covid should at least be offered the opportunity to take the antiviral.

How does paxlovid work?

Paxlovid, a drug developed by Pfizer, is an antiviral treatment consisting of three pills to be taken twice a day for five days. That makes it 30 pills in total. Paxlovid is actually two drugs: two of the three pills are nirmatrelvir, which stops the virus from replicating; the third pill is ritonavir, a drug once used in HIV/AIDS treatment, which boosts the effect of nirmatrelvir.

The earliest a covid patient starts taking paxlovid, the sooner and more easily the infection will clear. The treatment is effective if started within five days of symptoms, after which the antiviral can no longer be effective in stopping the virus from taking over.

The drug is highly effective in preventing severe illness—in the trials, patients were found to be 89% less likely to develop severe covid after taking it.

Who is eligible for paxlovid?

The antiviral is available for all people over the age of 12 who weigh at least 88 pounds (40 kg). The recommendation is to prescribe the medication to those at high risk of developing severe covid.

The list of conditions linked to higher risk of developing severe covid is long and includes physical inactivity, any history of smoking (those sneaky teenage cigarettes do count), or mental health issues such as depression and anxiety. That means pretty much all Americans qualify.

There are, however, a lot of prescription drugs that interact with paxlovid. Some of them make the treatment contraindicated, while others require temporary adjustments, such as a change in dosage or a suspension of the other medication.

Notably, women who are on hormonal birth control should use other means of contraception while taking the medication and until one menstrual period after the end of the treatment.

What are the side effects of paxlovid?

Like all medications, paxlovid has side effects, including increased blood pressure, diarrhea, muscle pain, and altered taste. In particular, people report a bitter, metallic taste in their mouths.

In some patients, paxlovid appears to cause a “rebound effect:” people might feel better during the treatment, then experience some symptoms again a few days after the course is done. However, this is still under investigation, and scientists are evaluating extending the treatment period.

Where can I buy paxlovid, and how much is it?

Paxlovid is currently available at about 20,000 locations across the country, including community health centers and pharmacies with in-house clinics where the prescription can be filled right after a positive test. More locations are being added, and there is a live map to help patients find the closest to them.

The treatment costs about $530 per course, but it’s free to patients at least until the emergency officially ends. However, some clinics and doctors might charge for the visit and prescription.

Read More

Share196Tweet123Share49
Editor

Editor

  • Trending
  • Comments
  • Latest
Canada’s OSC Flags Tweets From Coinbase, Kraken CEOs

Canada’s OSC Flags Tweets From Coinbase, Kraken CEOs

February 22, 2022
Trudeau Invokes Rare Emergency Powers To Shut Down ‘Freedom Convoy’ Blockades

Trudeau Invokes Rare Emergency Powers To Shut Down ‘Freedom Convoy’ Blockades

February 15, 2022
S&P 500 confirms correction as stocks stumble on war fears

S&P 500 confirms correction as stocks stumble on war fears

February 23, 2022
Scholz to warn Putin of western resolve on Ukraine

Scholz to warn Putin of western resolve on Ukraine

0
Waning stockpiles drive widespread global commodity crunch

Waning stockpiles drive widespread global commodity crunch

0
FT Global MBA Ranking 2022: US business schools dominate

FT Global MBA Ranking 2022: US business schools dominate

0
A Wild Time Capsule in North Dakota Is This Week’s Most Popular Home

A Wild Time Capsule in North Dakota Is This Week’s Most Popular Home

June 25, 2022
5 Lovely Lake Homes Priced Below a Million Bucks

5 Lovely Lake Homes Priced Below a Million Bucks

June 25, 2022
Clarence Thomas: Court Should Reconsider Gay Marriage, Birth Control Decisions Next After Overturning Roe

Clarence Thomas: Court Should Reconsider Gay Marriage, Birth Control Decisions Next After Overturning Roe

June 25, 2022
WallStreetReview

Copyright © 2022. WallStreetReview.com

Navigate Site

  • About
  • Advertise
  • Privacy & Policy
  • Contact

Follow Us

No Result
View All Result
  • Home
  • News

Copyright © 2022. WallStreetReview.com

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Don't miss the

NEWSLETTER

Exclusive editorial

Breaking News

Quality Company Coverage

Expert Writers

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

WallStreetReview will use the information you provide on this form to be in touch with you and to provide updates and marketing.